Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions.
about
Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.Chemiluminescent immunoassay technology: what does it change in autoantibody detection?Current and emerging techniques for ANCA detection in vasculitis.Antineutrophil cytoplasmic antibodies testing in a large cohort of unselected greek patients.Anti-neutrophil cytoplasmic autoantibodies: a renewed paradigm in periodontal disease pathogenesis?Relationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosis.Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trialPulmonary vasculitis in the intensive care unit.Clinical aspects of indirect immunofluorescence for autoimmune diseases.Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.Emergency testing for antineutrophil cytoplasmic antibodies combined with a dialog-based policy between clinician and biologist: effectiveness for the diagnosis of ANCA-associated vasculitis.Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener's autoantigen.Clinical features of bilateral progressive hearing loss associated with myeloperoxidase-antineutrophil cytoplasmic antibody.Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.Discrepancies between two immunoassays for the determination of MPO and PR3 autoantibodies.Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis.[Paradigm shift in ANCA diagnostics : New international consensus recommendations].
P2860
Q33684065-7FC05225-549E-422E-B67A-91FD35745F14Q33830773-D665CF54-200C-4E69-A77B-E058AFA5CB7EQ34422614-6E3514B0-3DDB-40AE-8096-82D317A884BDQ35038822-B8207057-5682-4E15-8024-6E09A0470EDFQ36553578-297FE63B-0735-4C79-84F0-D5D83D29B1AFQ36843060-EE0980FF-4251-43EE-A604-077D45EA25D2Q37144563-70B71794-0D2F-43CE-B47D-C3F471F0FD97Q37861390-BDF0E1B0-6ACD-46F4-8B9C-A5CA1AFA4FA1Q38382986-25307A1D-4F7D-4853-B3A8-A05B3C5A11F7Q40041740-53F083F6-6176-4272-83DC-B3854278B6FDQ41958938-FF3AB73D-2C1D-4122-8B72-481741CE4488Q42034393-4FCAA959-8B28-4041-ADD7-6BBDF40A0429Q44919018-AA70CDA0-C585-4DFA-A804-5E920EEB2E04Q47581564-C57712B9-35DD-4D05-A4EA-8DED7317C0BCQ50879150-C1EAB7A7-FE56-4FA6-AFEC-029017C96CF4Q51013683-27859F77-DEB0-4445-BB47-BEEFA69B372CQ53591253-AC54C776-E144-4854-82D3-D34E0B641A11
P2860
Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Detection of anti-neutrophil c ...... l clinical testing conditions.
@en
Detection of anti-neutrophil c ...... l clinical testing conditions.
@nl
type
label
Detection of anti-neutrophil c ...... l clinical testing conditions.
@en
Detection of anti-neutrophil c ...... l clinical testing conditions.
@nl
prefLabel
Detection of anti-neutrophil c ...... l clinical testing conditions.
@en
Detection of anti-neutrophil c ...... l clinical testing conditions.
@nl
P2093
P356
P1433
P1476
Detection of anti-neutrophil c ...... l clinical testing conditions.
@en
P2093
Darrell R Schroeder
Elaine Wiegert
Henry A Homburger
Kimberly A Russell
Ulrich Specks
P304
P356
10.1006/CLIM.2001.5200
P577
2002-05-01T00:00:00Z